0001104659-11-018298.txt : 20110401 0001104659-11-018298.hdr.sgml : 20110401 20110401184157 ACCESSION NUMBER: 0001104659-11-018298 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110401 FILED AS OF DATE: 20110401 DATE AS OF CHANGE: 20110401 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TRANZYME INC CENTRAL INDEX KEY: 0001274644 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 631192270 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4819 EMPEROR BOULEVARD, SUITE 400 CITY: DURHAM STATE: NC ZIP: 27703 BUSINESS PHONE: 919 313-4760 MAIL ADDRESS: STREET 1: 4819 EMPEROR BOULEVARD, SUITE 400 CITY: DURHAM STATE: NC ZIP: 27703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Desjardins-Innovatech S.E.C. CENTRAL INDEX KEY: 0001516029 STATE OF INCORPORATION: A8 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35119 FILM NUMBER: 11733048 BUSINESS ADDRESS: STREET 1: 2 COMPLEXE DESJARDINS, #1717 STREET 2: P.O. BOX 760 CITY: MONTREAL STATE: A8 ZIP: H5B 1B8 BUSINESS PHONE: 15142817131 MAIL ADDRESS: STREET 1: 2 COMPLEXE DESJARDINS, #1717 STREET 2: P.O. BOX 760 CITY: MONTREAL STATE: A8 ZIP: H5B 1B8 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Capital regional et cooperatif Desjardins CENTRAL INDEX KEY: 0001516038 STATE OF INCORPORATION: A8 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35119 FILM NUMBER: 11733049 BUSINESS ADDRESS: STREET 1: 2 COMPLEXE DESJARDINS, #1717 STREET 2: P.O. BOX 760 CITY: MONTREAL STATE: A8 ZIP: H5B 1B8 BUSINESS PHONE: 15142817131 MAIL ADDRESS: STREET 1: 2 COMPLEXE DESJARDINS, #1717 STREET 2: P.O. BOX 760 CITY: MONTREAL STATE: A8 ZIP: H5B 1B8 3 1 a3.xml 3 X0203 3 2011-04-01 0 0001274644 TRANZYME INC TZYM 0001516038 Capital regional et cooperatif Desjardins 2 COMPLEXE DESJARDINS, #1717 P.O. BOX 760 MONTREAL, QUEBEC, CANADA H5B 1B8 0 0 1 0 0001516029 Desjardins-Innovatech S.E.C. 2 COMPLEXE DESJARDINS, #1717 P.O. BOX 760 MONTREAL, QUEBEC, CANADA H5B 1B8 0 0 1 0 Common Exchangeable Shares of Tranzyme Pharma Inc. Common Stock 14497 D Preferred Exchangeable Shares of Tranzyme Pharma Inc. Common Exchangeable Shares of Tranzyme Pharma Inc. 1217804 D Common Exchangeable Shares of Tranzyme Pharma Inc. Common Stock 29721 I By Desjardins-Innovatech S.E.C. These shares of Tranzyme Pharma Inc. will be exchanged for shares of Common Stock of the Issuer upon the closing of the Issuer's initial public offering, which is anticipated to occur on April 6, 2011, in a corporate reorganization. These shares are immediately exercisable and have no expiration date. These shares of Tranzyme Pharma Inc. will be converted into Common Exchangeable Shares of Tranzyme Pharma Inc. immediately prior to the closing of the Issuer's initial public offering, which is anticipated to occur on April 6, 2011, in a corporate reorganization. These shares are immediately exercisable and have no expiration date. These securities are owned of record by Capital regional et cooperatif Desjardins, and ultimate control over voting and investment determinations with respect to the shares held by Capital regional et cooperatif Desjardins are made by the board of directors of Capital regional et cooperatif Desjardins, which is comprised of the following directors: Marlene Deveaux, Michael Dorosz, Maurice Doyon, Francine Ferland, Josee Fortin, Pierre Gauvreau, Evangeliste Bourdages, Andre Lachapelle, Steve Lepage, Jean-Claude Loranger, Bruno Morin, Jacques Plante and Claudine Roy, each of whom disclaims beneficial ownership of such securities except to the extent of his or her pecuniary interest therein. These securities are owned of record by Desjardins-Innovatech S.E.C. Ultimate control over voting and investment determinations with respect to the shares held by Desjardins-Innovatech S.E.C. are made by the board of directors of Capital regional et cooperatif Desjardins, which is comprised of the following directors: Marlene Deveaux, Michael Dorosz, Maurice Doyon, Francine Ferland, Josee Fortin, Pierre Gauvreau, Evangeliste Bourdages, Andre Lachapelle, Steve Lepage, Jean-Claude Loranger, Bruno Morin, Jacques Plante and Claudine Roy, each of whom disclaims beneficial ownership of such securities except to the extent of his or her pecuniary interest therein. /s/ Renaud Lebuis, Legal Advisor and /s/ Gerald St. Aubin, Vice-President for Capital regional et cooperatif Desjardins 2011-04-01 /s/ Renaud Lebuis, Legal Advisor and /s/ Gerald St. Aubin, Vice-President for Desjardins - Innovatech S.E.C. 2011-04-01